CRA Financial Services
ACRS icon

CRA Financial Services’s Aclaris Therapeutics ACRS Stock Holding History

CRA Financial Services’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$93.5K Hold
17,782
– – 0.01% 327
2026
Q2 		$94.1K Hold
17,782
– – 0.01% 318
2026
Q1 		$66.7K Hold
17,782
– – 0.01% 293
2025
Q4 		$53.5K Hold
17,782
– – 0.01% 289
2025
Q3 		$33.8K Hold
17,782
– – ﹤0.01% 293
2025
Q2 		$25.3K Buy
+17,782
New +$24.1K ﹤0.01% 276

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Three Bridge Wealth Advisors
Three Bridge Wealth Advisors Los Altos, California $469M AUM 10.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

CRA Financial Services's ACRS Position: Q3 2026 in Review

CRA Financial Services held its Aclaris Therapeutics (ACRS) position steady in Q3 2026 at 17,782 shares worth $93.5K. The position accounts for 0.01% of the portfolio, ranked #327.

CRA Financial Services first reported a position in ACRS in Q2 2025 and has held it in 6 quarters since. The position peaked at $94.1K in Q2 2026. 67 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.

  • CRA Financial Services held 17,782 shares of Aclaris Therapeutics worth $93.5K as of Q3 2026.
  • CRA Financial Services left its Aclaris Therapeutics share count unchanged in Q3 2026.
  • Aclaris Therapeutics made up 0.01% of CRA Financial Services's portfolio in Q3 2026, its #327 holding.
  • CRA Financial Services first reported a position in Aclaris Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • CRA Financial Services's Aclaris Therapeutics position peaked at $94.1K in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.

Based on CRA Financial Services's 13F filing for Q3 2026, filed 16 Oct 2026.